Syndax Pharmaceuticals's total assets for Q2 2025 were $596.15M, a decrease of -6.95% from the previous quarter. SNDX total liabilities were $438.73M for the fiscal quarter, a 3.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.